Pharmaceutical composition for a hepatitis C viral protease inhibitor
PK201000591A0Undetermined Publication Date: 2010-07-16BOEHRINGER INGELHEIM INT GMBH
0 Cites 0 Cited by
Patent Information
- Application Number
- PK201000591
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2010-07-05
- Publication Date
- 2010-07-16
Abstract
The present invention relates to a liquid pharmaceutical composition comprising:(a) a compound of formula (1): or a pharmaceutically acceptable salt thereof; (b) one or more pharmaceutically acceptable lipids; and (c) one or more pharmaceutically acceptable hydrophilic surfactants; suitable for oral administration via a liquid- or semi-solid-filled capsule and method of using this composition for inhibiting the replication of the hepatitis C virus (HCV) and for the treatment of an HCV infection.
Need to check novelty before this filing date? Find Prior Art